LANCY(002612)2025-04-10 07:58Financial Performance - In 2024, the company achieved total revenue of approximately CNY 56.91 billion, a year-on-year decrease of 0.24% [2] - Gross profit margin was 58.85%, an increase of 1.38 percentage points compared to the previous year [2] - Net profit attributable to shareholders was approximately CNY 2.57 billion, up 1.58% year-on-year [2] - Net cash flow from operating activities was approximately CNY 5.67 billion, a decline of 35.61% year-on-year [2] Business Segment Performance - The medical beauty segment generated approximately CNY 27.84 billion in revenue, accounting for 48.92% of total revenue, with a year-on-year growth of 3.47% [3][9] - The women's clothing segment reported revenue of approximately CNY 19.25 billion, a decrease of 2.97%, representing 33.83% of total revenue [3] - The infant and child segment achieved revenue of approximately CNY 9.21 billion, down 5.53%, making up 16.19% of total revenue [3] Medical Beauty Brands Performance - Milan Division reported revenue of approximately CNY 12.65 billion, a year-on-year increase of 0.71% [4] - Crystal Skin Medical Beauty achieved revenue of approximately CNY 5.02 billion, a growth of 10.37% [4] - Hanchen Division generated revenue of approximately CNY 3.69 billion, up 8.36% [4] - Wuhan Wuzhou reported revenue of approximately CNY 2.12 billion, a decline of 3.03% [5][6] Asset and Equity Status - As of December 31, 2024, total assets were approximately CNY 79.71 billion, a decrease of 4.68% from the previous year [3] - Net assets attributable to shareholders were approximately CNY 27.87 billion, down 21.59% year-on-year [3] Future Strategy - The medical beauty segment is positioned as the primary business area, with plans to expand its national footprint and leverage opportunities in the beauty economy [9] - The company aims to build a "pan-fashion industry interconnected ecosystem" to enhance brand influence and market presence [9] Inventory Situation - As of the end of 2024, total inventory for women's clothing was approximately CNY 6.78 billion, a decrease of 3% from the previous year [9]